Name: DMIIU Income Statement - Drugs Made In America Acquisition Ii Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

DMIIU - Drugs Made In America Acquisition Ii Corp.

USD | NASDAQ

DMIIU Income Statement - Drugs Made In America Acquisition Ii Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25
Revenues
Revenues	-	-	-	-	-
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-
Selling & Marketing	-
Operating Income
Operating Income	(0.1)	-	(0.2)	-	(0.1)
Non-Operating
Interest Income	4.4	-	0.1	-	-
Interest Expense	-	-	-	-	-
Income From Equity Investments	-	-
Tax & Net
Income Tax Expense	-	-	-	-	-
Net Income From Continuing Ops	4.3	4.3	(0.0)	(0.0)	(0.1)
Net Income From Discontinued Ops	-
Per Share
EPS Basic	-	-	-	-	-
EPS Diluted	-	-	-	-	-
Shares Basic	-	-
Supplementary Data
EBITDA	-	-	-	-	-
EBIT	(0.1)	-	(0.2)	-	(0.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025
Revenues
Revenues	-	-
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses
Research & Development	-	-
Selling General & Administrative	-	-
Selling & Marketing	-	-
General & Administrative	-	0.5
Depreciation & Amortization	-	-
Amortization of Intangibles	-	-
Other Operating Expenses	-	-
Total Operating Expenses	-	0.5
Operating Income
Operating Income	-	(0.5)
Non-Operating
Interest Income	-	4.9
Interest Expense	-	-
Income From Equity Investments	-	-
Other Non-Operating Income	-	4.7
Pre-Tax Income
Tax & Net
Income Tax Expense	-	-
Net Income From Continuing Ops	8.6	4.2
Net Income From Discontinued Ops	-	-
Net Income	8.6	4.2
Net Income Attributable To Parent
Per Share
EPS Basic	-	-
EPS Diluted	-	-
Shares Basic	-	-
Shares Diluted	-	-
Supplementary Data
EBITDA	-	-
EBIT	-	(0.5)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)